Ambrisentan

Ambrisentan · Mylan Pharmaceuticals Inc.

Drug timelines are a Plus or Pro feature.

75 regulatory and trial events tracked for Ambrisentan, covering 2012-01-27 to 2026-02-17. Get the full timeline:

Most recent: FDA Approved: AMBRISENTAN — Supplemental Application (Actavis Pharma, Inc.)